← HHS Federal Register rules

Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganisms and Associated Resistance Marker Nucleic Acids Directly in Respiratory Specimens

fda-device · Food and Drug Administration · Rule · Published 2019-03-14 · Effective 2019-03-14 · 84 FR 9226

Document

Document number
2019-04719
Federal Register citation
84 FR 9226
CFR reference
21 CFR 866
Type
Rule
Action
Final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2019-03-14
Effective date
2019-03-14
HHS docket
Docket No. FDA-2019-N-0360

Abstract

The Food and Drug Administration (FDA or we) is classifying the device to detect and identify microorganisms and associated resistance marker nucleic acids directly in respiratory specimens into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the device to detect and identify microorganisms and associated resistance marker nucleic acids directly in respiratory specimens classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown